Nuvation Bio, Inc. (NUVB)

NYSE: NUVB · IEX Real-Time Price · USD
2.69
+0.10 (3.86%)
Aug 10, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Selling, General & Admin
24.2810.956.99
Research & Development
69.0432.625.11
Operating Expenses
93.3243.5532.1
Operating Income
-93.32-43.55-32.1
Interest Expense / Income
002.66
Other Expense / Income
-6.47-1.89-1.21
Pretax Income
-86.85-41.66-33.55
Net Income
-86.85-41.66-33.55
Net Income Common
-86.85-41.66-33.55
Shares Outstanding (Basic)
19898207
Shares Outstanding (Diluted)
19898207
Shares Change
102.90%-52.81%-
EPS (Basic)
-0.44-0.43-0.16
EPS (Diluted)
-0.44-0.43-0.16
Free Cash Flow Per Share
-0.35-0.38-0.12
EBITDA
-86.48-41.56-30.88
Depreciation & Amortization
0.370.10.01
EBIT
-86.85-41.66-30.89
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).